FRANCE: En Carta Diagnostics, a deeptech start-up developing rapid Point-of-Care (POC) molecular diagnostics kits, has announced €1.5M ($1.63M) in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its flagship indication, the debilitating Lyme disease, while ensuring its ability to scale industrially. 

The startup led by the Raiola brothers and supported by IAG and Italians in VC Partners is revolutionizing healthcare access with an AI platform for musculoskeletal services. 

Lola Cares, a pioneering health tech company, has announced the successful closure of its first funding round, raising £250,000 from SFC Capital. A significant step towards the emerging company’s mission to enhance the care experience in an overstretched social care sector. The funding is set to enhance Lola’s conversational AI capabilities and broaden its impact in the care sector. 

Angel Academe has made its 50th investment in PreActiv, an innovative platform that optimises patients before surgery, using technology to create individualised prehabilitation programmes. 

Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital. Series A financing to advance clinical development of lead candidate RLS-1496 into Phase 1 studies this year in chronic atopic dermatitis and chronic psoriasis. Financing will also advance respiratory program, recipient of a substantial CIRM grant last year, to development candidate nomination for idiopathic pulmonary fibrosis.

Edinburgh-based biotechnology firm, Calcivis, has secured £5m in funding to roll out its cutting-edge dental technology.

The firm's patented system enables early detection of tooth decay - which in turn can enable timely preventive treatment - by deploying a biologic diagnostic agent in combination with an imaging device. Calcivis aims to revolutionise early-intervention diagnostics in dentistry. Its innovative technology uses bioluminescence to highlight quickly and clearly where preventive measures are required before decay becomes irreversible.

Animal Health Angels has made its first investment is in Marleybones, a female founded business which is a fresh dog food brand known for its unique pantry fresh® solution.

This is part of a £900k seed funding led by JamJar Investments, the venture capital firm set up by the founders of innocent drinks, and further supported by Active Partners, the consumer investor behind Soho house, Rapha and KatKin. The funds will be used to grow the Marleybones team, expand its presence in both online and offline channels and broaden its retail footprint after its recent UK launches in Waitrose and Whole Foods Market.

Bridgend-based AI technology firm Clinithink is helping to improve patient care, relieve workloads for stretched clinicians and deliver significant savings to the NHS with investment from the Development Bank of Wales.

CryoLogyx, a University of Warwick spinout redefining cell technology through cryopreservation, has closed an oversubscribed seed funding round. The £500,000 investment came from private UK business angels and the Wider Oxford Technology Angel Network (WOTAN), which includes previous investors Oxford Technology Management. 

Newcastle University spinout Jetbio is introducing 3D bioprinting products in the global multi-billion-dollar 3D bioprinting market for drug discovery, tissue engineering and regenerative medicine.

Newcells Biotech, whose laboratory models are used in drug development and reduce reliance on animal testing, has raised a further £2.35m to boost its growth and help establish itself as a global leader in its field. 

The Newcastle-based company has secured funding from existing investors including the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures, Mercia’s own funds and Northstar Ventures. It brings the total raised by the company to date to over £12m.

ITALY: The Investors Club has invested in the 10 million euro round of Resalis Therapeutics.  The club gave a special thanks to its champion Guido Bonazzola, who contributed in a fundamental way to the realization of this initiative. Guido's active participation and commitment helped make this significant investment possible.